Adher Alsayed
Overview
Explore the profile of Adher Alsayed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alshamsan B, Elshenawy M, Aseafan M, Fahmy N, Badran A, Elhassan T, et al.
Oncol Lett
. 2024 Jul;
28(3):429.
PMID: 39049989
The present study aimed to clarify the prognostic role of the pre-treatment neutrophil-to-lymphocyte ratio (NLR) for the response to neoadjuvant chemotherapy (NAC) in locally advanced breast cancer (LABC). Due to...
2.
Alshamsan B, Suleman K, Agha N, Abdelgawad M, Alzahrani M, Elhassan T, et al.
Int J Womens Health
. 2022 Mar;
14:373-384.
PMID: 35309953
Purpose: Obesity is prevalent in Saudi Arabia and is associated with adverse clinical features and poor breast cancer (BC) outcomes. We determined the distribution of body mass index (BMI) and...
3.
Alshamsan B, Alshibany A, Elshenawy M, Badran A, Elhassan T, Ajarim D, et al.
Cancer Manag Res
. 2022 Jan;
13:9411-9420.
PMID: 35002318
Purpose: The correlation between the preoperative neutrophil-to-lymphocyte ratio (NLR) and Oncotype DX (ODX) recurrence score (RS) has not yet been established. We aimed to investigate the association between NLR and...
4.
Suleman K, Mushtaq A, Haque E, Badran A, Ajarim D, Elashwah A, et al.
Breast Care (Basel)
. 2021 Mar;
16(1):59-65.
PMID: 33716633
Introduction: Human epidermal growth factor receptor 2 (HER-2) targeted therapy regimens can improve tumor response in HER-2-positive metastatic breast cancer (MBC), with overall survival benefits. Objective: We evaluated the efficacy...
5.
Osmani A, Tulbah A, Alsayed A, AlShanqeeti A, Al-Twegieri T, Ajarim D, et al.
Am J Case Rep
. 2021 Feb;
22:e928012.
PMID: 33544698
BACKGROUND Invasive lobular carcinoma is special subtype of breast cancer that has clinical behavior and morphology distinct from other breast cancer subtypes. It accounts for 5-15% of breast cancer. Overall,...
6.
Suleman K, Almalik O, Haque E, Mushtaq A, Badran A, Alsayed A, et al.
Oncology
. 2020 Jan;
98(3):168-173.
PMID: 31918425
Background: There is a paucity of literature examining the impact of timing of surgery after neoadjuvant chemotherapy. Objective: This study aimed to analyze the impact of the time taken to...
7.
Johani B, Al Malik O, Anwar E, Tulbah A, Alshabanah M, Alsayed A, et al.
Breast J
. 2016 Nov;
23(1):119.
PMID: 27797125
No abstract available.
8.
A L-Tweigeri T, Alsayed A, Alawadi S, Ibrahim M, Ashour W, Jaafar H, et al.
Cancer Chemother Pharmacol
. 2015 Nov;
77(1):147-53.
PMID: 26563257
Purpose: To evaluate the efficacy and safety profile of the (FEC100) followed by cisplatin/docetaxel with and without trastuzumab as primary chemotherapy for patients with locally advanced breast cancer (LABC). Methods:...
9.
Owaidah T, AlGhasham N, Alghamdi S, Alkhafaji D, Alamro B, Zeitouni M, et al.
Thromb J
. 2014 Dec;
12(1):28.
PMID: 25530719
Introduction: Venous thromboembolism (VTE) requires urgent diagnosis and treatment to avoid related complications. Clinical presentations of VTE are nonspecific and require definitive confirmation by imaging techniques. A clinical pretest probability...
10.
Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, et al.
BMC Cancer
. 2007 Dec;
7:222.
PMID: 18053234
Background: Breast cancer in young Saudi women is a crucial problem. According to the 2002 annual report of Saudi National Cancer Registry, breast cancers that developed before the age of...